Coagulase-negative staphylococci: Difference between revisions
From IDWiki
Content deleted Content added
No edit summary |
|||
| Line 1: | Line 1: | ||
= Coagulase-negative Staphylococci (CoNS/CNSt) = |
|||
= Organisms = |
= Organisms = |
||
Revision as of 23:33, 14 August 2019
Organisms
- Staphylococcus epidermidis group
- S. epidermidis
- S. capitis
- S. simulans
- ?S. warneri
- S. haemolyticus group
- S. haemolyticus
- S. hominis
- S. devriesei
- S. saprophyticus: mainly causes UTIs
- S. massiliensis
- S. lugdenensis: has more in common with S. aureus and should never be considered a contaminant
- Unclear grouping
- S. lyticans
- S. pettenkoferi
- S. petrasii
- S. pseudolugdunensis
Management
- Generally resistant to beta lactams
- First-line: vancomycin
- Alternatives: linezolid, daptomycin, Septra, ciprofloxacin, doxycycline
References
- ^ Antonio Ramos-Martínez, Patricia González-Merino, Elena Suanzes-Martín, Marta Murga-de la Fuente, Gabriela Escudero-López, Ane Andrés-Eisenhofer, Esther Expósito-Palomo, Andrea Gutierrez-Villanueva, Itziar Diego-Yagüe, Elena Múñez, Ana Fernandez-Cruz, Jorge Calderón-Parra. Risk of endocarditis among patients with coagulase-negative Staphylococcus bacteremia. Scientific Reports. 2023;13(1). doi:10.1038/s41598-023-41888-7.
- ^ Sara F. Haddad, Brian D. Lahr, Sebastian Santos Patarroyo, Supavit Chesdachai, Kami D. Kies, John C. O’Horo, Daniel C. DeSimone, Parham Sendi, Larry M. Baddour. Bloodstream Infection Due to Coagulase-Negative Staphylococci: Impact of Species on Prevalence of Infective Endocarditis. Antibiotics. 2023;12(9):1453. doi:10.3390/antibiotics12091453.
